Elias Karam/LinkedIn
Jul 4, 2025, 15:43
Elias Karam: New Treatments for HCC Were Presented at ESMO GI 2025
Elias Karam, Hematology-Medical Oncology Fellow at Gustave Roussy, shared a post on LinkedIn:
“Live from ESMO GI 2025 Barcelona
New HCC treatments:
- Novel checkpoints (TIGIT, TIM-3)
- CAR-T, TCR, bispecific engagers
- Targeting β-catenin, HDAC, oncolytic viruses
Focus: 5-year survival, cure, QoL.”
More posts featuring ESMOGI25
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 4, 2025, 15:49
Jul 4, 2025, 15:45
Jul 4, 2025, 15:43
Jul 4, 2025, 15:14
Jul 4, 2025, 14:05
Jul 4, 2025, 10:23